Pharma IQ | 10/22/2010
Public awareness of biobanking is growing and lack of transparency can lead to closure of a biobanking project. David Kaufman, Director of Research and Statistics Genetics and Public Policy Center, John Hopkins University, speaks to Andrea Charles from Pharma IQ, about the growing public interest in biobank research and the concerns and opinions of potential participants. Kaufman also discusses the challenges for biobanking recruitment and retention and future developments...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More